...Alkaline Phosphatase (ALK), PSA, bone scan (BSD2), CT scan (CTD2), race. At time of D3, we documented status of bone sca...
...ALK inhibitor brigatinib is active in patients with ALK-rearranged non-small cell lung cancer. Patients who had previous...
...ALK, ROS1 and RET rearrangements in non-adenocarcinoma NSCLC patients.,ALK, ROS1 and RET rearrangements were screened by...
To evaluate the performance and treatment profile of advanced EML4-ALK positive Non-small cell lung cancer (NSCLC) patie...
...ALK) gene. In an astoundingly brief period following the recognition of ALK-positive NSCLC, details of the biology, clin...
...ALK binding in a panel of ALK(+) cell lines, and correlated the findings with the ALK structure and its interactions wit...
...ALK fusion in additional two cases with NRG1 fusions. When comparing overall survival (OS) according to the presence of ...
...ALK (6/30), NRAS (4/30), ATRX (3/30), BRAF (2/30), HRAS (2/30), KRAS (1/30). In 17/30 ATC (54 %) mutations were found in...
...ALK inhibitors in ALK-rearranged non-small cell lung cancer and found that an increased frequency and distinct spectrums...
...ALK-negative ALCLs is usually worse than ALK-positive ALCLs. In this case, the patient was not responsive to a multidrug...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269